Press Review

AYOXXA launches LUNARIS Protein Analysis System in Asia

Founded in 2010 as a spin-off of the National University of Singapore, AYOXXA Biosystems is one of the success stories of Singapore’s Biotech start-up community. It has since grown into a global biotech company headquartered in Cologne, Germany, and it remains focused on the development and commercialization of its proprietary technology for advanced protein analysis, LUNARIS™. AYOXXA Living Health Technologies Pte. Ltd., a Singapore-based subsidiary of AYOXXA, is collaborating closely with the Singapore Eye Research Institute (SERI), the research arm of Singapore National Eye Center (SNEC), to develop and market the LUNARIS™ platform in Asia.


Still have any questions? Ask us!

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.